[Use of methadone in obstetric and gynecologic management of drug-dependent females with and without HIV infection].
In the course of obstetrical and gynecological care, 113 women with acute intravenous drug use (IVD) participated in a methadon detoxification. In addition to medical treatment, socio-paedagogical intervention was part of the approach. A total of 212 cycles of methadon detoxification have been administered since patients' relapse during or after detoxication had a chance of readmission. In 45% of the attempts, detoxification could be fully achieved. An investigation of actual drug behaviour of the participating women in October 1990 showed, that 23.9% had abstained from drug consumption for at least 6 months ("drug free"). According to the HIV status and pregnancy 4 groups with comparable age (mean 27.7 years) and duration of drug dependency (mean 7.5 years) were classified. There were remarkable differences in drug behaviour between these groups. Of the HIV-infected women treated during pregnancy, 36% were drug free. Of the HIV-infected women without pregnancy and pregnant women without HIV-infection, comparable proportions (approx. 27% each) were living without drugs. All but one HIV-negative women of the group without pregnancy (3.8%) consumed drugs. In conclusion, pregnancy and subsequent motherhood seems to enhance and stabilize the motivation to quit drug consumption. The significant difference between the HIV-negative and HIV-positive women without pregnancy suggests, that besides pregnancy, the awareness of HIV-infection and of a limited life expectancy has also a positive influence on drug behaviour.
Universitätsfrauenklinik Klinikum Rudolf Virchow Berlin UFK.
A
A
Schäfer
M
M
Eck
U
U
Bell
W
W
Heckmann
B
B
Schwartländer
D000328:Adult; D000553:Ambulatory Care; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006679:HIV Seropositivity / Q000523:psychology; D006556:Heroin Dependence / Q000523:psychology / Q000534:rehabilitation*; D006760:Hospitalization; D006801:Humans; D007231:Infant, Newborn; D009042:Motivation; D010349:Patient Compliance / Q000523:psychology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D011256:Pregnancy Outcome; D012803:Sick Role; D015819:Substance Abuse, Intravenous / Q000523:psychology / Q000534:rehabilitation*
Der Einsatz von Methadon bei der geburtschilflichen und gynäkologischen Versorgung von drogenabhängigen Frauen mit und ohne HIV-Infektion.